{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:34:04Z","timestamp":1790818444729,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Budget of Department of Medical Biology Nicolaus Copernicus University Toru\u0144 Poland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3836-x","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T08:55:45Z","timestamp":1513328145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic significance of RBP2-H1 variant of JARID1B in melanoma"],"prefix":"10.1186","volume":"17","author":[{"given":"\u0141ukasz","family":"Ku\u017abicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Stanek-Widera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara W.","family":"Chwirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"3836_CR1","doi-asserted-by":"crossref","first-page":"19226","DOI":"10.1073\/pnas.0700735104","volume":"104","author":"Y Xiang","year":"2007","unstructured":"Xiang Y, Zhu Z, Han G, Ye X, Xu B, Peng Z, et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci U S A. 2007;104:19226\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3836_CR2","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.4238\/2015.May.22.11","volume":"14","author":"LH Zhao","year":"2015","unstructured":"Zhao LH, Liu HG. Immunohistochemical detection and clinicopathological significance of JARID1B\/KDM5B and P16 expression in invasive ductal carcinoma of the breast. Genet Mol Res. 2015;14:5417\u201326.","journal-title":"Genet Mol Res"},{"key":"3836_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12885-016-2108-5","volume":"16","author":"OA Bamodu","year":"2016","unstructured":"Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, et al. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. BMC Cancer. 2016;16:160.","journal-title":"BMC Cancer"},{"key":"3836_CR4","doi-asserted-by":"crossref","first-page":"12723","DOI":"10.18632\/oncotarget.3713","volume":"6","author":"B Tang","year":"2015","unstructured":"Tang B, Qi G, Tang F, Yuan S, Wang Z, Liang X, et al. JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN\/AKT signaling in hepatocellular carcinoma cells. Oncotarget. 2015;6:12723\u201339.","journal-title":"Oncotarget"},{"key":"3836_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13046-016-0311-5","volume":"35","author":"D Wang","year":"2016","unstructured":"Wang D, Han S, Peng R, Jiao C, Wang X, Yang X, et al. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27. J Exp Clin Cancer Res. 2016;35:37.","journal-title":"J Exp Clin Cancer Res"},{"key":"3836_CR6","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s13277-014-2859-z","volume":"36","author":"L Wang","year":"2015","unstructured":"Wang L, Mao Y, Du G, He C, Han S. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer. Tumour Biol. 2015;36:2465\u201372.","journal-title":"Tumour Biol"},{"key":"3836_CR7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ccr.2014.04.024","volume":"25","author":"S Yamamoto","year":"2014","unstructured":"Yamamoto S, Wu Z, Russnes HG, Takagi S, Peluffo G, Vaske C, et al. JARID1B is a luminal lineage-driving oncogene in breast cancer. Cancer Cell. 2014;25:762\u201377.","journal-title":"Cancer Cell"},{"key":"3836_CR8","first-page":"87","volume":"5","author":"Z Wang","year":"2014","unstructured":"Wang Z, Tang F, Qi G, Yuan S, Zhang G, Tang B, et al. KDM5B is overexpressed in gastric cancer and is required for gastric cancer cell proliferation and metastasis. Am J Cancer Res. 2014;5:87\u2013100.","journal-title":"Am J Cancer Res"},{"key":"3836_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3892\/ijmm.2016.2614","volume":"38","author":"L Fang","year":"2016","unstructured":"Fang L, Zhao J, Wang D, Zhu L, Wang J, Jiang K. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma. Int J Mol Med. 2016;38:172\u201382.","journal-title":"Int J Mol Med"},{"key":"3836_CR10","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.1007\/s13277-015-3418-y","volume":"36","author":"X Shen","year":"2015","unstructured":"Shen X, Zhuang Z, Zhang Y, Chen Z, Shen L, Pu W, et al. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression. Tumour Biol. 2015;36:7133\u201342.","journal-title":"Tumour Biol"},{"key":"3836_CR11","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/modpathol.3800413","volume":"18","author":"A Roesch","year":"2005","unstructured":"Roesch A, Becker B, Meyer S, Wild P, Hafner C, Landthaler M, et al. Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod Pathol. 2005;18:1249\u201357.","journal-title":"Mod Pathol"},{"key":"3836_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 2010;141:583\u201394.","journal-title":"Cell"},{"key":"3836_CR13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. 2013;23:811\u201325.","journal-title":"Cancer Cell"},{"key":"3836_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CMR.0b013e32835d5d6f","volume":"23","author":"\u0141 Ku\u017abicki","year":"2013","unstructured":"Ku\u017abicki \u0141, Lange D, Str\u0105czy\u0144ska-Niemiec A, Chwirot BW. JARID1B expression in human melanoma and benign melanocytic skin lesions. Melanoma Res. 2013;23:8\u201312.","journal-title":"Melanoma Res"},{"key":"3836_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ijc.10644","volume":"101","author":"A Barrett","year":"2002","unstructured":"Barrett A, Madsen B, Copier J, PJ L, Cooper L, Scibetta AG, et al. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer\/testis antigen? Int J Cancer. 2002;101:581\u20138.","journal-title":"Int J Cancer"},{"key":"3836_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1242\/dmm.000331","volume":"1","author":"JD Fackenthal","year":"2008","unstructured":"Fackenthal JD, Godley LA. Aberrant RNA splicing and its functional consequences in cancer cells. Dis Model Mech. 2008;1:37\u201342.","journal-title":"Dis Model Mech"},{"key":"3836_CR17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mc.22341","volume":"55","author":"H Liu","year":"2016","unstructured":"Liu H, Liu L, Holowatyj A, Jiang Y, Yang ZQ. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer. Mol Carcinog. 2016;55:977\u201390.","journal-title":"Mol Carcinog"},{"key":"3836_CR18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2007.03.001","volume":"25","author":"K Yamane","year":"2007","unstructured":"Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell. 2007;25:801\u201312.","journal-title":"Mol Cell"},{"key":"3836_CR19","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1128\/MCB.00274-07","volume":"27","author":"AG Scibetta","year":"2007","unstructured":"Scibetta AG, Santangelo S, Coleman J, Hall D, Chaplin T, Copier J, et al. Functional analysis of the transcription repressor PLU-1\/JARID1B. Mol Cell Biol. 2007;27:7220\u201335.","journal-title":"Mol Cell Biol"},{"key":"3836_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/PAI.0000000000000170","volume":"24","author":"\u0141 Ku\u017abicki","year":"2016","unstructured":"Ku\u017abicki \u0141, Lange D, Str\u0105czy\u0144ska-Niemiec A, Chwirot BW. Altered splicing of JARID1B in development of human Cutaneous melanoma? Appl Immunohistochem Mol Morphol. 2016;24:188\u201392.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3836_CR21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1742-4658.2012.08547.x","volume":"280","author":"E Heroes","year":"2013","unstructured":"Heroes E, Lesage B, G\u00f6rnemann J, Beullens M, Van Meervelt L, Bollen M. The PP1 binding code: a molecular-lego strategy that governs specificity. FEBS J. 2013;280:584\u201395.","journal-title":"FEBS J"},{"key":"3836_CR22","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1128\/MCB.23.24.9389-9404.2003","volume":"23","author":"L Li","year":"2003","unstructured":"Li L, Ren CH, Tahir SA, Ren C, Thompson TC. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine\/threonine protein phosphatases PP1 and PP2A. Mol Cell Biol. 2003;23:9389\u2013404.","journal-title":"Mol Cell Biol"},{"key":"3836_CR23","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.18632\/oncotarget.14790","volume":"8","author":"ND Facompre","year":"2017","unstructured":"Facompre ND, Harmeyer KH, Basu D. Regulation of oncogenic PI3-kinase signaling by JARID1B. Oncotarget. 2017;8:7218\u20139.","journal-title":"Oncotarget"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T02:29:34Z","timestamp":1570501774000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3836-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3836"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3836-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"854"}}